Drug Profile
SAR 399063
Alternative Names: DHA-GLP + vit D; SAR-399063Latest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Sanofi
- Class Antihyperlipidaemics; Glucagon-like peptides; Hormones; Omega 3 fatty acids; Small molecules; Vitamins
- Mechanism of Action Insulinotropin agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Muscular atrophy
Most Recent Events
- 15 Feb 2016 Discontinued - Phase-III for Muscular atrophy in France (unspecified route)
- 31 Mar 2013 Phase-III clinical trials in Muscular atrophy in France (unspecified route)
- 27 Apr 2012 Phase-I clinical trials in Muscular atrophy in France (unspecified route)